NYU Langone Medical Center
New York, 10016, United States
NCT Number: NCT02270359
The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction (MI) and non-obstructive coronary artery disease (CAD) using optical coherence tomography (OCT). Additionally, cardiac magnetic resonance imaging (CMR) will be used to detect myocardial abnormalities, which will be correlated to OCT findings to gain insight into the mechanisms of MI in patients with non-obstructive coronary artery disease (i.e. "open arteries").
This study is active but is not currently recruiting participants.
21 year–99 year
All sexes
Interventional
Not applicable
New York, 10016, United States
In this single center, observational study, patients of both sexes with MI who are referred for cath will be enrolled. Those who have no obstructive CAD on clinically indicated coronary angiography, defined as no stenosis of >50% in any major epicardial vessel, will undergo coronary OCT just after the clinically indicated diagnostic angiogram, and CMR within 1 week, typically within 72-96 hours. Participants will be followed for clinical events for at least 1 year. 20 fully eligble participants will be recruited at NYU Langone Medical Center and Bellevue Hospital Center among a projected 200 enrolled patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Optical coherence tomography (OCT): Intracoronary imaging for amount and type of plaque as well as plaque rupture, ulceration, dissection and/or thrombosis.
Cardiac magnetic resonance imaging (CMR): MRI of the heart to identify areas of infarction (damage) and/or edema (smelling)
Gadolinium contrast will be administered during CMR
Time frame: 1 Week
Time frame: 1 week
Time frame: 1 Year
NYU Langone Health
Other
Research on Infarction With Open Arteries Using OCT and CMR (RIO)
Acronym: RIO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005152
Angina Pectoris, Brain Diseases
View Trial DetailsNCT04260958
Cardiovascular Diseases, Heart Diseases
Borås, Sweden
View Trial DetailsNCT05859620
Cardiovascular Diseases, Heart Diseases
Innsbruck, Tyrol, Austria
View Trial DetailsNCT05818475
Cardiovascular Diseases, Heart Diseases
Bologna, BO, Italy
View Trial Details